Pharmacokinetics and brain distribution of tetrahydropalmatine and tetrahydroberberine after oral administration of DA-9701, a new botanical gastroprokinetic agent, in rats

Biological & Pharmaceutical Bulletin
Ji Won JungHee Eun Kang

Abstract

DA-9701, a new botanical gastroprokinetic agent, has potential for the management of delayed gastric emptying in Parkinson's disease if it has no central anti-dopaminergic activity. Therefore, we examined the pharmacokinetics of DA-9701 components having dopamine D2 receptor antagonizing activity, tetrahydropalmatine (THP) and tetrahydroberberine (THB), following various oral doses (80-328 mg/kg) of DA-9701. The distribution of THP and THB to the brain and/or other tissues was also evaluated after single or multiple oral administrations of DA-9701. Oral administration of DA-9701 yielded dose-proportional area under the plasma concentration-time curve (AUC0-8 h) and maximum plasma concentration (Cmax) values for THP and THB, indicating linear pharmacokinetics (except for THB at the lowest dose). THP and THB's large tissue-to-plasma concentration ratios indicated considerable tissue distribution. High concentrations of THP and THB in the stomach and small intestine suggest an explanation for DA-9701's potent gastroprokinetic activity. The maximum concentrations of THP and THB in brain following multiple oral DA-9701 for 7 d (150 mg/kg/d) was observed at 30 min after the last oral DA-9701 treatment: 131±67.7 ng/g for THP and 6.97±...Continue Reading

References

Dec 1, 1984·British Journal of Clinical Pharmacology·J S ShindlerJ D Parkes
May 21, 2008·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Tae Ho LeeMirim Jin
Aug 20, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Michela BarichellaGianni Pezzoli
Sep 16, 2011·Journal of Gastroenterology and Hepatology·Eun Ran KimPoong-Lyul Rhee
Dec 12, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Y-S JungK J Lee
Apr 24, 2013·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Ju Myung KimHee Eun Kang
Nov 23, 2013·Biomolecules & Therapeutics·Yong Sam Kwon, Miwon Son
Jan 15, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Ji Won JungHee Eun Kang

❮ Previous
Next ❯

Citations

Aug 8, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Ji-Hyun ChoiHee Tae Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.